Product Overview

What is Cervarix

Cervarix is a vaccine intended to protect females against the diseases caused by infection with Human Papillomavirus types 16 and 18.

These diseases include:

• Cervical cancer (cancer of the lower part of the uterus or womb) and
• Precancerous lesions of the female genitals (changes in cells of the cervix, vulva and vagina that have a risk of turning into cancer).

How does Cervarix work:

• Cervarix works by causing the body’s own defences to make antibodies against Human Papillomavirus types 16 and 18.
• Cervarix will not protect against all types of Human Papillomavirus; types 16 and 18 are responsible for approximately 70% of cervical cancer cases and 70% of HPV-related pre-cancerous lesions of the vulva and vagina.
• Cervarix vaccine is not infectious and cannot cause the diseases related to Human Papillomavirus infections.

How is Cervarix given:

• Cervarix is given as an injection into the muscle of the upper arm.
• A complete course of Cervarix consists of 3 doses, the first given on an agreed date and the second and third given 1 and 6 months later.
• Cervarix is intended for use in females from 9 years of age onwards.

For further information on Cervarix please see:

• Cervarix Patient Information Leaflet (PIL)